OIA 2024 25 073 Document for release.pdf

Document 1

CONFIDENTIAL – NOT FOR DISTRIBUTION

MEMORANDUM FOR PHARMAC BOARD MEETING 27 AUGUST 2024

To:
Pharmac Board
From:
Chief Executive
Date:
August 2024
Item:
3.3
Rōpū Māori external advisory group (Rōpū) – Options for Board consideration
Recommendations
It is recommended that the Board:
note the LOE, GPS and the Minister of Health’s Cabinet paper, Vision and priorities
the   1982
to address Māori health need (12 August 2024)
note the current approach to partnership with te Rōpū and the Board
Act
consider the options for the future of te Rōpū relationship with the Board provided in
this paper; and
under
resolve to make a decision based on the options provided or defer for further
discussion.
Purpose of Paper
This paper is supplementary to the summary briefing provided to the Pharmac Board Chair,
in July 2024. It sets out options for the Board in consideration of the LOE, GPS and the
emerging strategic direction for Pharmac in relation to the Board in its work with Te Rōpū.
Strategic Direction
Information

Released
Pharmac is required to give effect to the GPS and the Minister for Pharmac’s Letter of
Expectations (LOE). Both signal a shift away from a Tiriti o Waitangi approach to Māori
health, to one more focused on driving improvements in Māori health outcomes and
achieving health targets. Alignment between the LOE and the GPS are shown in Appendix 1.
The Minister of Health’s Cabinet paper, Vision and priorities to address Māori health need
also provides further direction for the wider health system, including Pharmac (Appendix 2).
Official
Background:
The refresh of Te Whaioranga Māori Responsiveness Strategy Te Rautaki o Te Whaioranga
(Te Whaioranga) was formally announced and released into the public domain in December
2020. Within Te Whaioranga the priority area Māori Leadership and Advice has the overall
aim of increasing and supporting Māori participation in governance, leadership and
management decision-making at all levels. A key action in the strategy is the establishment
of a Māori Advisory Rōpū to guide Pharmac senior leaders and Board.
A1820007

The Rōpū has been set up to assist Pharmac to:
Give effect to Pharmac’s commitment to upholding Te Tiriti o Waitangi and
understand and support whānau Māori to achieve best health and wellbeing through
access to, and optimal use of, medicines and medical devices.
The composition of Te Rōpū is comprised of members nominated by our existing Māori
Health Professional Bodies (MHPB) - Te Ohu Rata o Aotearoa (Te ORA Māori medical
professionals), Ngā Kaitiaki o te Puna Rongoa (MPA Māori Pharmacists Association), Te
Rūnanga o Aotearoa – Tōpūtanga Tāpuhi Kaitiakitanga o Aotearoa (Māori Nurses), Ngā Pou
Mana Tangata Whenua Al ied Health (NPM) together with the 2 Whānau Ora Commissioning
agencies.
Status of Te Rōpū
Te Rōpū is not a statutory commit ee to the Pharmac Board and as such, functions as a
partner to Te Pātaka Whaioranga Pharmac Board as agreed in the paper to the Board in
February 2024. Both the Board and Te Rōpū acknowledge that statutory accountability for Te
Pātaka Whaioranga Pharmac, including for the exercise of Te Pātaka Whaioranga
Pharmac’s functions and powers, including decision-making, resides with the Board under
the   1982
the Crown Entities Act.
The Role of Te Rōpū
Act
Te Rōpū provides strategic Māori advice and input to the Board and Te Pātaka Whaioranga
Pharmac. At a high level, the Rōpū provides:  under
•  advice and guidance on te Tiriti o Waitangi excellence.
•  Shared input into key organisational policies decision-making
•  Shared input into key project, clinical and strategy governance decision-making
•  assistance to understand and support whānau Māori to achieve best health and
wellbeing through access to, and optimal use of, medicines and medical devices.
Partnership framework
The Board and Te Rōpū have worked to progress the partnership discussion and to align a
Released
Information
shared vision and a shared decision-making approach.  On 24 August 2023, a strategic
Wānanga was held between the Board and Te Rōpū members to seek clarification of these
arrangements and allow for finalisation of the Terms of Reference for Te Rōpū.
The Board/ Rōpū partnership framework was approved by the Board at the Board meeting in
February this year. At that juncture however, it was agreed by both the Board and Te Rōpū
that more work was needed to further affirm the principles for the partnership and to clarify
how the 2 parties wil  work together to fulfil the purposes of the partnership.
Official
The review of the TOR that would further inform the relationship is in its final stages and at
this stage has not been formally approved.
Discussion
Shifting perspectives
It should be noted that a key driver behind the formation of Te Rōpū was to meet our
obligations under the auspices of Te Tiriti and to work towards building a Tiriti based
partnership with an external Māori advisory group.
A1820007

2 of 4

This is set out in the strategic priority area Māori leadership and advice within Te
Whaioranga Māori Responsiveness Strategy as a key outcome.
As described above in the section on the role of Te Rōpū, the discussion has moved from a
Māori advisory commit ee being tasked with providing guidance to Board and SLT to one of
shared decision making, shared strategy development and input into matters of governance.
Board should deliberate on whether there is stil  an appetite to continue in this direction.
Changing focus
Changes in the operating environment wil  require Pharmac to give effect to the GPS and
shift to a focus on targets and Māori health outcomes. This wil  require an increased
emphasis on data and evidence, and to shift decision making and resources in the health
system closer to communities, and to work with partners within the health system and
beyond.
The GPS signals a discernible shift to the 15 Iwi Māori Partnership Boards (IMPB’s) as a key
source of leadership, advice, and guidance. There is also the Hauora Māori Advisory
Committee (HMAC) of Manatū Hauora which has a critical system monitoring role. Currently
Pharmac is listed as one of the Crown entities subject to the monitoring function of this
committee however there has been no engagement with HMAC to this point.
the   1982
The Board should consider in the current environment whether Te Rōpū should maintain a
similar role or whether Pharmac would be bet er placed to work with these IMPB and HMAC
instead.
Act
Pre-existing relationships
As previously touched on Te Rōpū is comprised of members nominated and selected from
under
existing our Māori Health Professional Bodies (MHPB’s) and Whānau Ora Commissioning
Agencies with whom we have had existing longstanding relationships. The relationships with
the MHPB’s are currently being strengthened with a view to moving from a transactional
partnership to one which has added value for both organisations. Pharmac has existing
MOA’s with these groups.
Something of high strategic value would be a partnership with the MHPB’s that allowed for
input into our clinical assessment and decision-making processes. Also of note is that the
MHPB’s have significant reach with a collective membership exceeding 5500. Through this
membership cohort and in negotiation with the MHPB’s there is a potential opportunity to
extend reach into communities, Māori whānau and patient voice.
Released
Information
The situation of having Te Rōpū and the MHPB’s resourced at the same time to work with
Pharmac should also be considered in these deliberations.
We are currently reviewing the value of working in partnership with the Whānau Ora
Commissioning Agencies. There is a relatively high outlay for this relationship with limited
value coming back to Pharmac.
Options  Official
1.  Continue with the partnership framework with Te Rōpū and further develop and affirm
the principles of engagement, partnership, responsibility, and accountability. This would
require a series of hui with Te Rōpū to clarify and reach agreement on how the
partnership wil  operate.
2.  Reorient the partnership with Māori by shifting resource to the partnership arrangements
currently in place with the MHPB’s, supplemented by building relationships with IMPB’s
and HMAC
3.  Reserve a decision pending further discussion.
A1820007

3 of 4

the 1982
Act
under
Released
Information
Official

   COMMERCIAL IN CONFIDENCE

MEMORANDUM FOR BOARD : OCTOBER 2024

To:
Pharmac Directors
From:
Chief Executive
Date:
October 2024
Item:
1.0
Future Māori Engagement and Partnership
Recommendations
It is recommended that the Board:
agree our planned future approach to engagement and partnership with Māori
stakeholders
resolve to disestablish Te Rōpū and move to enhance relationships with key clinical
the   1982
Māori professional groups
agree to meet with Te Rōpū as soon as possible and earlier than 29 October 2024,
to communicate their decision.
Act
Purpose
under
This paper provides the Board with an update on our planned future approach to engage
and partner with Māori.
Strategic Direction
In keeping with the provisions of the Pae Ora (Healthy Futures) Act 2022 (the Act),
Pharmac’s strategic direction embeds its commitment to upholding the articles and principles
of Te Tiriti. This sits alongside:
•
Our statutory objective in the Act “to secure for eligible people in need of
Released
Information
pharmaceuticals, the best health outcomes that are reasonably achievable from
pharmaceutical treatment and from within the amount of funding provided”
•
The direction set in our Māori Responsiveness Strategy (Te Whaioranga) which
intersects with all of Pharmac’s strategic priority areas, organisational policies, and
strategies
•
Alignment with the Pae Tū: Hauora Māori Strategy 20231
Official
•
Our Statement of Intent 2023/24-2026/27 as a tool for ensuring te Tiriti is applied to all
strategic priorities under ‘Organisational Excellence’ and
•
Our Statement of Performance Expectations 2024/25 which includes a reference to
contributing to health equity and giving effect to the Tiriti policy.

1 Required to be prepared by the Minister of Health pursuant to s. 42 of the Act.
A1833638

COMMERCIAL IN CONFIDENCE
Background
At its meeting on 27 August 2024, the Board agreed to review current arrangements with the
Māori advisory group, Te Rōpū and to:
•
reorient the partnership with Māori by shifting resource to the partnership
arrangements currently in place with the Māori Health Professional Bodies (MHPBs),
supplemented by building relationships with Iwi Māori Partnership Boards (IMPBs) and
the Hauora Māori Advisory Committee (HMAC) of Manatū Hauora, which plays a
critical system monitoring role.
It should be noted that at the time the Rōpū was formed in 2020, that the environment within
Pharmac was quite different. The Māori advisory capacity within Pharmac was minimal and
Māori staffing levels were relatively low. We did not have our Tiriti and Equity policies and
the Māori Directorate was not in place. At the time, the formation of a Māori body to provide
advice and guidance to Pharmac, was supported to address the needs of the Organisation.
This was to be on a fixed term of three years, followed by a review.
Since that time, the needs of the Organisation have evolved. The current government have
the
changed the strategic direction for the health system and our Tiriti and Equity policies are
1982
now in place.  We now have two Māori Directors on SLT, four Māori staff at principal advisor
level and a general increase in Māori staff numbers within Pharmac. Our relationships with
our Māori health professional bodies have also grown over this time and we have built
relationships with other parts of the sector, including Pou Hauora Directorate of the Ministry
Act
of Health and the former Māori Health Authority.
under
He mihimihi / acknowledgements
The Board were unequivocal in their views that Te Rōpū are a group of Māori with significant
mana and standing, not only among whānau, hapu and iwi, but within their respective
professions where they are all held in high regard.
The level of expertise across a wide range of health domains is evident with the skill
composition of Te Rōpū, ranging from Clinical Pharmacy, Clinical Psychology, Clinical
Nursing, Clinical Anaesthesia, General Practice and Public Health to Policy, Governance,
Strategic leadership, Te Tiriti o Waitangi, Kaupapa Māori Research, Law and Commerce,
Information
Audit and Risk, to name a few.
Released
On this basis, it is appropriate that the contribution of former and current members of Te
Rōpū is acknowledged and valued. Pharmac Te Pātaka Whaioranga have received the
generosity of Te Rōpū in terms of guidance, advice and the provision of insights to improve
our work for Māori.
He mihinui ki Te Rōpū, kua whai take nā koutou ki te whakatō purapura hei wheiao mo Te
Pataka Whaioranga, hei wheiao mō te iwi. E tika ana te tuku mihi mō ngā mahi i
Official
whakatakotohia e Te Rōpū kei mua i ā tatou katoa. He haerenga, he hui wānanga, he
whakaputanga whakaaro i runga i ngā tini ahuatanga o ō tatou mahi katoa. Otirā kāre e
mutu ngā mihi ki tēnei puna Rangatira. Tēna koutou, tēnā koutou, tēna koutou katoa.

A1833638

COMMERCIAL IN CONFIDENCE
Planned way forward
The Board are committed to engagement with Māori and want to increase that, both in terms
of Pharmac specific activity and also working in collaboration with our health sector partners.
In order to take this new and improved way of working forward, we plan to:
•
Align more specifically to the Government’s approach to the Act, the GPS and the
Minister’s Letter of Expectation, particularly in the areas of partnership with
stakeholders, pursuing any opportunities to work collaboratively and collectively with
other entities, government and non-government, where partnership will result in
process improvements, health gains, or enable efficiencies.
•
Continue to engage closely with Ministry of Health, in particular the Deputy
Director-General Māori Health and team over the coming months. This is important
from a strategic standpoint as the Pae Tū Hauora Māori Strategy is currently being
renewed by the Ministry. With the expiration of our own Te Rautaki ō Te Whaioranga
Māori Responsiveness Strategy, alignment to the new Pae Tū will have significant
importance. This includes how we give effect to Pae Tū as an organisation through Te
the
Whaioranga.
1982
•
Complete a review of our partnerships with the Whānau Ora Commissioning Agencies.
We noted in August there is a relatively high outlay for this relationship with limited
value coming back to Pharmac. The review will include examining whether our limited
Act
resources are better utilised in other areas of Māori stakeholder relationships.
•
under

Seek to engage with the Hauora Māori Advisory Committee (HMAC). This is a
committee of the Minister of Health that monitors system performance for Māori at a
national level and advises the Minister on progress, risks and opportunities for Māori
health (noting that as a Crown Entity, Pharmac is subject to HMAC’s monitoring
function). HMAC have nine population priorities within its monitoring system
performance remit for Māori health, including communicable diseases, cancers,
diabetes, cardiovascular disease, and complex co-morbidities.
•
Shift resource to strengthen the long-term partnership arrangements currently in place
with the four Māori Health Professional Bodies. Discussions are now underway with
these groups, focusing on strategic partnerships and improved collaboration.
Released
Information
•
Seek to build relationships with the Iwi Māori Partnership Boards IMPBs. These boards
wil  be an invaluable link into Māori communities with decision making roles at a local
level. The Minister of Health has required each IMPB to develop community plans
based on local health priorities.
•
Continue discussions with Māori Clinical Networks within Health NZ. Each of the
Clinical Networks work in specific areas of Māori health. With the current focus on
Māori population health need
Official   there is great potential to work collaboratively with these
groups. Early discussions between Pharmac’s Director Advice & Assessment/CMO
and Kaituruki Director Māori with clinical leaders have been positive.
A draft plan for Māori advice, partnership, collaboration, and engagement is provided in
Appendix One.

A1833638

the 1982
Act
under
Released
Information
Official

COMMERCIAL IN CONFIDENCE
Next steps
1.
Set up an online meeting with Board to inform Te Rōpū of decision.
2.
Board discuss with Te Rōpū options for final, in person meeting.
3.
Kaituruki Director Māori to inform Māori Directorate staff of Board decision.
4.
Inform all staff of Board decision.
5.
SLT to discuss impact on Māori Directorate and way forward.

Appendices
Appendix One:  Programme of work for Māori Advice, Partnership, Collaboration and
Engagement.
the   1982

Board Members
By adding your signature to this document, it is taken that you approve the
Act
recommendations as detailed on page one:  under

Paula Bennett, Chair

Date

Peter Bramley, Deputy Chair

Date

Released
Information
Talia Anderson-Town, Board member

Date

Diana Siew, Board member

Date

Official
Margaret Wilsher, Board member

Date

A1833638

the 1982
Act
under
Released
Information
Official

EMAIL 1
From:
Jacqui Webber
To:
Rebecca Mason; Eugene Berryman-Kamp
Cc:
Board Chair
Subject:
Letter from Pharmac Board Chair re Te Rōpū
Date:
Tuesday, 22 October 2024 3:18:00 pm
Attachments:
2024-10-22 Chair letter to Te Ropu Co-chairs.pdf
Tēnā kōrua

Please find attached a letter from Hon Paula Bennett, following your recent hui.

We look forward to receiving your response with regard to holding a formal
poroporoākī/poroākī on 29 October at Pharmac.  We would appreciate your response
by Thursday 24 October so that arrangements can be made.

Ngā mihi

Jacqui
the   1982

Jacqui Webber | Board Secretary and EA to Board Chair
________________________________________________________________________________
______
Act

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
under
s 9(2)(a)
|  www.pharmac.govt.nz

Released
Information
Official

EMAIL 1 + ATTACHMENT

Level 9, 40 Mercer Street, Wellington
PO Box 10 254, Wellington 6143
P: 0800 660 050
www.pharmac.govt.nz

22 October 2024

Rebecca Mason
Eugene Berryman-Kamp
Co-Chairs, Te Rōpū

By email
s 9(2)(a)
   s 9(2)(a)


the   1982
Tēnā kōrua Rebecca Mason rāua kō Eugene Berryman-Kamp

Board decision to disestablish Te Rōpū

Act
Thank you for meeting with myself, Talia Anderson-Town and Pharmac senior staff on Friday
18 October 2024.

under
As discussed in our meeting, this letter is to confirm the Board decision to disestablish Te
Rōpū. The Board has been giving a lot of thought on how best to work alongside Māori, after
I received the Minister’s Letter of Expectations and in the context of our wider operating
environment.

As I noted in the meeting, addressing the health needs of all New Zealanders, with the
greatest health needs in our communities, is a priority. The Board is well aware that Māori
have worse health outcomes than non-Māori across most measures of health and that
Pharmac plays an important role in ensuring there is equal access to medicines and medical
devices.

Released
Information
The decision to disestablish Te Rōpū was done in order to strengthen Pharmac’s other
partnership arrangements and relationships. Pharmac will now look to focus on those
relationships we have in place (ie four Māori health professional bodies) and look to build
strong connections with iwi Māori partnership Boards and the Hauora Māori Advisory
Committee within Ministry of Health.

Pharmac and the Board acknowledge the value and expert advice and guidance Te Rōpū
have provided since its formation in 2021. These contributions have left an indelible mark on
Official
our work and our aspirations to do more for Māori in medicines and devices.

If appropriate, I would like to offer a formal poroporoākī/poroākī with Te Rōpū, Board and
staff, to close this kaupapa in the most appropriate way, on 29 October at Pharmac. Please
let us know if Te Rōpū members are still available on this date and we will hold the flights
that were in place for the meeting previously planned for this date.

Once again, I thank you and the members of Te Rōpū for your work with Pharmac and wish
you all the best for the future.

Ngā mihi

Hon Paula Bennett
Chair, Pharmac Board

cc
Associate Minister of Health
Pharmac Board
the   1982
Act
under
Released
Information
Official
A1840057 -
2

Subject:    FW: RESPONSE NEEDED Māori Engagement paper for Board
EMAIL 2
Sent:
10/10/2024, 9:04:17 am
From:
Sarah Fitt<[email address]>
To:
Trevor Simpson
Cc:
Jacqui Webber
This was the plan from Paula on Tuesday and your paper has gone out to Board for review and decision.
Suggest when you speak to co-chairs today can say Board are having some discussions on future of Te Ropu, post LoE etc and
Board Chair will be calling them shortly directly to discuss.
Plan for their meeting to go ahead on 24th (which some Board members may attend, TBC ) and cancel meeting on 29th
Sarah
Sarah Fitt | Chief Executive
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10-254 | Level 9, 40 Mercer Street, Wellington
DDI: +64 4 901 3218 | P: +64 4 460 4990 | s 9(2)(a)
|www.pharmac.govt.nz
From: Board Chair <[email address]>
the   1982
Sent: Tuesday, October 8, 2024 2:58 PM
To: Jacqui Webber <[email address]>; Paula Bennett - Board Chair <[email address]>; Sarah Fitt
<[email address]>
Subject: Re: RESPONSE NEEDED Māori Engagement paper for Board
Act
Hi Sarah and jacqui
under
Can you please send this out to the board for it to be approved via email.
I propose that in the first instance we advise the Minister under no surprises and then  I set up a call with the
co-chairs to let them know the boards decision - perhaps with Talia, nicola and Trevor on the call too? And ask
them how they would like the decision to be discussed with the other Te Ropu members. Ie. Via a Teams call
with me and some board members or by themselves.
I would advise them that their meeting this months would be their last (Jacqui, can you remind me when this
is?) and that we won't be doing the special board meeting with them at the end of the month.
Information
I would be interested in others views on this way forward?
Released
thanks
From: Jacqui Webber <[email address]>
Sent: Friday, October 4, 2024 3:22 PM
To: Paula Bennett - Board Chair <[email address]>
Official
Cc: Board Chair <[email address]>
Subject: RESPONSE NEEDED Māori Engagement paper for Board
Hi Paula
Here’s the Māori Engagement paper for your review.
Can you please let me know whether you would like a Board call set up to discuss this, or whether you are happy for
me to email by circular to Board for their decision.  Thanks
Ngā mihi
Jacqui
Jacqui Webber | Board Secretary and EA to Chair
_____________________________________________________________________________________

Subject:    Fwd: Can I please have a brief on Te Ropu? history what it currently does. any cost?
EMAIL 3
Sent:
17/07/2024, 12:29:11 pm
From:
Sarah Fitt<[email address]>
To:
Trevor Simpson
Cc:
Jacqui Webber
Trevor
Can you pull together a short briefing for Paula to discuss at their Board only session next Thursday
Should include the recommendations that we recently discussed esp in  light of LoE.
We can discuss more tomorrow at our catch up
Sarah
Sarah Fitt
Chief Executive
PHARMAC
From: Board Chair <[email address]>
Sent: Wednesday, July 17, 2024 12:09:18 PM
To: Jacqui Webber <[email address]>; Sarah Fitt <[email address]>
Subject: Can I please have a brief on Te Ropu? history what it currently does. any cost?the   1982
Act
under
Released
Information
Official

Subject:    Notes for you from 10am hui
EMAIL 4
Sent:
18/10/2024, 11:04:11 am
From:
Nicola Ngawati<[email address]>
To:
Trevor Simpson
Follow Up Flag:
Follow up
Flag Status:
Flagged
Kia ora
A few notes of main points from Co-Chairs which I think we should go through with rest of SLT at Directors only on Monday
Rebecca
-very disappointed with the news
-Pharmac does not have a good track record engaging with Māori. Don’t see how this will change going forward
-Many previous reports note this fact.
-not correct to talk about Māori engagement – should be about partnership with Māori
-very concerned about the safety of kaimahi Māori at Pharmac
-one of the practices TR followed was to connect in with kaimahi Māori at each hui so that they had an avenue to connect through
the   1982
TR into senior leaders.
-well known that Pharmac is a culturally unsafe environment for kaimahi Māori
-sad that the avenue of TR will now be closed for kaimahi Māori
-worries about how kaimahi Māori will cope
Act
-look back at the previous reviews including racism review.
-noted Pharmac’s obligations under Pae Ora in relation to Māori. Board decision to disestablish TR don’t detract from that.
s 9(2)(g)(i)
under
Eugene
-very disappointed
-other TR members will be disappointed.
-noted Paula is well aware of the depth and breadth of experience of TR members
-he and Rebecca will need time to digest and discuss how they want this news conveyed to TR members.
-requested a note from the Board on what the decision is and the reasons for this. Asked for this before their TR teams hui on
24 October. Trevor to follow this up thanks
Released
Information
-they will let Paula now how they want the decision communicated
-Noted that the TR will want a poroporoaki in Wellington to formally conclude TR. Soon. Not in a few months. Up to TR members if
they wish to attend.
-decision not a shock in the political environment but anticipate reverberations . this will hit kaimahi Māori hard and be noticed
across the sector.
Mauri ora
Official
Nicola
Dr Nicola Ngawati| Director - Equity and Engagement
Te Pātaka Whaioranga | Pharmac
s 9(2)(a)

Subject: Re: Can I please have a brief on Te Ropu? history what it currently does. any cost?
EMAIL 5
Sent:
17/07/2024, 12:38:34 pm
From:
Sarah Fitt<[email address]>
To:
Jacqui Webber; Trevor Simpson
This won’t be ready for the weekend and will need to go in Directors only section early next week
Sarah Fitt
Chief Executive
PHARMAC
From: Jacqui Webber <[email address]>
Sent: Wednesday, July 17, 2024 12:33
To: Sarah Fitt <[email address]>; Trevor Simpson <[email address]>
Subject: RE: Can I please have a brief on Te Ropu? history what it currently does. any cost?
Hi Both
Is it possible to have this on Friday for me to publish their papers for the weekend to read?
the 1982
Ngā mihi
Jacqui
Act
Jacqui Webber | Board Secretary
s 9(2)(a)
www.pharmac.govt.nz
under
From: Sarah Fitt <[email address]>
Sent: Wednesday, July 17, 2024 12:29 PM
To: Trevor Simpson <[email address]>
Cc: Jacqui Webber <[email address]>
Subject: Fwd: Can I please have a brief on Te Ropu? history what it currently does. any cost?
Trevor
Can you pull together a short briefing for Paula to discuss at their Board only session next Thursday
Should include the recommendations that we recently discussed esp in light of LoE.
Released
Information
We can discuss more tomorrow at our catch up
Sarah
Sarah Fitt
Chief Executive
PHARMAC
Official
From: Board Chair <[email address]>
Sent: Wednesday, July 17, 2024 12:09:18 PM
To: Jacqui Webber <[email address]>; Sarah Fitt <[email address]>
Subject: Can I please have a brief on Te Ropu? history what it currently does. any cost?

Subject:    RE: Te Rōpū hui - 24th and 29th
EMAIL 6
Sent:
8/10/2024, 9:35:05 am
From:
Sarah Fitt<[email address]>
To:
Trevor Simpson
Cc:
Jacqui Webber
Follow Up Flag:
Follow up
Flag Status:
Flagged
Kia ora Trevor
Paula mentioned it yesterday, She has had an initial review of the paper and will have some more feedback on it for you.
Her plan is then to have a teams call with co-chairs, share the paper with them and then ask Board to attend their next meeting.
Not sure if she wants to have a Board meeting/call to review and approve the paper before she speaks to c-chairs. Jacqui may
want to confirm this with Paula and come back to you
Ngā mihi,
Sarah
Sarah Fitt | Chief Executive
the   1982
___________________________________________________________________
PHARMAC | Te Pātaka Whaioranga | PO Box 10-254 | Level 9, 40 Mercer Street, Wellington
DDI: +64 4 901 3218 | P: +64 4 460 4990 | s 9(2)(a)
|www.pharmac.govt.nz
Act
From: Trevor Simpson <[email address]>
Sent: Tuesday, October 8, 2024 9:14 AM
under
To: Sarah Fitt <[email address]>
Subject: FW: Te Rōpū hui - 24th and 29th
Kia ora Sarah,
Please see below from Rebecca. Wondering if we are anyway forward with the Board on this before I think about a response?
Ngā mihi
Trevor Simpson | Kaituruki Māori |Director Māori
Released
Information
___________________________________________________________________
Te Pātaka Whaioranga Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
DDI: +64 4 830 8499 | P: +64 4 460 4990 | s 9(2)(a)
| www.pharmac.govt.nz
From: Rebecca s 9(2)(a)
Sent: Monday, October 7, 2024 4:46 PM
Official
To: Rongo Toelupe <[email address]>; Leanne Manson <[email address]>; Trevor Simpson
<[email address]>
Cc: Eugene Berryman-Kamp s 9(2)(a)
Subject: Te Rōpū hui - 24th and 29th
Kia ora koutou,
Hope you are all well, as we head towards the end of the year.
I was just thinking that it’s been a while since we had an update from Pharmac and so it would be helpful if
you could send out a quick summary email to Te Rōpū for both our hui on the 24th and 29th confirming:
the time/location
agenda

Ngā mihi,
Rebecca
the 1982
Act
under
Released
Information
Official

Subject:    RUN SHEET for 10am
EMAIL 7
Sent:
18/10/2024, 9:42:32 am
From:
Nicola Ngawati<[email address]>
To:
Trevor Simpson

From: Nicola Ngawati
Sent: Thursday, October 17, 2024 3:46 PM
To: Jacqui Webber <[email address]>
Cc: Sarah Fitt <[email address]>; Trevor Simpson <[email address]>
Subject: Your teams meeting - Friday 18 October at 10am with Te Ropu Co-Chairs: Run sheet

Kia ora Jacqui
Can you please pass the following email to Paula thanks
Nicola

++++++

Kia ora Paula
the   1982
As requested please find below an outline/run sheet for your teams meeting at 10am tomorrow.
Regards
Nicola

Act

under
Friday 18 October 2024- 10-10.30am

Run sheet teams call with Te Rōpū Co-Chairs (Eugene Berryman-Kamp & Rebecca Mason)

Also present: Trevor Simpson (Director Māori Directorate), Nicola Ngawati (Director Equity and Engagement) and Talia
Anderson (Board Member)

Purpose of meeting:

-Advise Eugene and Rebecca of Board decision to disestablish Te Rōpū
-provide some background
Released
Information
-thank them for their valued contribution and those of the wider Te Rōpū members
-ask how they would like to convey the decision to the rest of Te Rōpū (do they wish to do this or would they prefer you
do this via teams).

10.00 - 10.05
Brief welcome – thanks for making the time to meet (Paula)
Pass to Trevor for an opening karakia
10.05 - 10.10
Introductions – led by Paula
10.10 – 10.15
Paula – why are we here?
Official

The Board has been giving a lot of thought to how best to engage
with Māori after I received the Minister’s Letter of Expectations and
in the context of our wider operating environment

Reinforce that addressing the health needs of Māori as a
population group with the greatest health needs in our communities
remains a priority

Well aware that Māori have the worse health outcomes than non-
Māori across most measures of health.

Have called this meeting to let you know of the Board decision to
disestablish Te Rōpū

Note this was done in order to strengthen Pharmac’s other
partnership arrangements and relationships with other groups

Pharmac will now look to focus on those relationships we have in
place (ie: four Māori health professional bodies) and look to build
strong connections with iwi Māori partnership Boards and the
Hauora Māori Advisory Committee within Ministry of Health.

Acknowledge that value Pharmac and the Board have placed on
the expert advice Te Rōpū have provided to Pharmac since Te
Rōpū was formed in 2021.

10.15 - 10.18
Pass to Trevor to acknowledge Te Roopu’s contribution
10.18 - 10.27
Allow opportunity for Eugene and Rebecca to respond/ask questions
10. 28 - 10.30
Closing karakia (Trevor)

the 1982
Act
under
Released
Information
Official